ACAD - Acadia Pharmaceuticals Inc
IEX Last Trade
16.59
0.270 1.627%
Share volume: 907,400
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$16.32
0.27
1.65%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-03 | 2023-02-28 | 2023-05-08 | 2023-08-03 | 2023-11-03 | 2024-02-28 | 2024-05-09 | |
| Total revenue | 134.563 M | 130.714 M | 136.490 M | 118.462 M | 165.235 M | 211.699 M | 231.041 M | 205.831 M | |
| Cost of revenue | 2.667 M | 2.136 M | 2.413 M | 1.667 M | 7.459 M | 14.622 M | 17.890 M | 22.951 M | |
| Gross profit | 131.896 M | 128.578 M | 134.077 M | 116.795 M | 157.776 M | 197.077 M | 213.151 M | 182.880 M | |
| -2.52% | 4.28% | -12.89% | 35.09% | 24.91% | 8.16% | -14.20% | |||
| Operating expenses | 165.547 M | 159.444 M | 180.140 M | 170.379 M | 154.739 M | 254.853 M | 178.207 M | 167.670 M | |
| Selling general and admin | 89.901 M | 78.108 M | 104.402 M | 101.235 M | 95.968 M | 97.890 M | 111.466 M | 107.991 M | |
| Research and development | 75.646 M | 81.336 M | 75.738 M | 69.144 M | 58.771 M | 156.963 M | 66.741 M | 59.679 M | |
| Total expenses | 168.214 M | 161.580 M | 182.553 M | 172.046 M | 162.198 M | 269.475 M | 196.097 M | 190.621 M | |
| -3.94% | 12.98% | -5.76% | -5.72% | 66.14% | -27.23% | -2.79% | |||
| Operating income | -33.651 M | -30.866 M | -46.063 M | -53.584 M | 3.037 M | -57.776 M | 34.944 M | 15.210 M | |
| Ebit | -33.651 M | -30.866 M | -46.063 M | -53.584 M | 3.037 M | -57.776 M | 34.944 M | 15.210 M | |
| Pretax income | -33.568 M | -26.415 M | -40.890 M | -44.939 M | 6.343 M | -52.143 M | 39.703 M | 21.002 M | |
| -21.31% | 54.80% | 9.90% | -114.11% | -922.06% | -176.14% | -47.10% | |||
| Income tax | 443.000 K | 768.000 K | 835.000 K | -1.918 M | 5.229 M | 13.033 M | -6.094 M | 4.447 M | |
| Net income basic | -34.011 M | -27.183 M | -41.725 M | -43.021 M | 1.114 M | -65.176 M | 45.797 M | 16.555 M | |
| 20.08% | -53.50% | -3.11% | 102.59% | -5,950.63% | 170.27% | -63.85% | |||
| Net income | -34.011 M | -27.183 M | -41.725 M | -43.021 M | 1.114 M | -65.176 M | 45.797 M | 16.555 M | |
| 20.08% | -53.50% | -3.11% | 102.59% | -5,950.63% | 170.27% | -63.85% |